Focus
Neuroscience Investors: Angels and VC Firms
The RaiseHunt database lists 144 Neuroscience investors: 85 angel investors and 59 people at 23 firms. Most list Seed and Series A among their stages; the largest hubs are Boston, San Francisco and London.
Strongest in Boston, San Francisco and London
- 144
- Neuroscience investors
- 85
- Angel investors
- 59
- People at VC/PE firms
- 23
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
144 Neuroscience investors
Showing 1-20
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
Ross Youngs CEO & Co-Founder at Univenture | Dublin, United States | AngelOperator angel | ClimateHealthcare | View profile | |
Jordan Curnes Co-Founder at IrishAngels | Milwaukee, United States | AngelOperator angel | ConsumerHardware | View profile | |
Evan Schwartz Board Observer at Prox Ventures | Boston, United States | AngelOperator angel | AIHealthcare | View profile | |
Olivier Njamfa Startup Investor at Seed4Soft | Paris, France | AngelOperator angel | HealthcareSaaS | View profile | |
Rajul Jain Managing Director at Vida Ventures | Santa Monica, United States | Angel | Healthcare | View profile | |
Stuart Lewtan angel investor and operator angel | Boston, United States | AngelOperator angel | EducationHealthcare | View profile | |
Joe Kraus angel investor and operator angel | Palo Alto, United States | AngelOperator angel | ClimateHealthcare | View profile | |
Josh Wolfe angel investor and operator angel | New York City, United States | AngelOperator angel | AIFinTech | View profile | |
Zach Piester angel investor | Atlanta, United States | Angel | AIConsumer | View profile | |
Erik Qualman angel investor | Austin, United States | Angel | EducationFinTech | View profile | |
Finn Age Hänsel angel investor and operator angel | Berlin, Germany | AngelOperator angel | CommerceConsumer | View profile | |
Alice Zhang angel investor and operator angel | San Francisco, United States | AngelOperator angel | AIHealthcare | View profile | |
Jake Winebaum angel investor and operator angel | Santa Monica, United States | AngelOperator angel | FinTechHealthcare | View profile | |
Jess Smith angel investor | Sydney, Australia | Angel | Healthcare | View profile | |
Jannah Boudreaux angel investor | Los Angeles, United States | Angel | AIConsumer | View profile | |
Imran Eba angel investor | Boston, United States | Angel | Healthcare | View profile | |
Harry Nelson angel investor and operator angel | Los Angeles, United States | AngelOperator angel | HealthcareSaaS | View profile | |
Adam Gazzaley angel investor and operator angel | San Francisco, United States | AngelOperator angel | AIHardware | View profile | |
Jerry Neumann angel investor | New York, United States | Angel | AIHealthcare | View profile | |
James Hyland angel investor and operator angel | Carmen, United States | AngelOperator angel | AIConsumer | View profile |
104 of 144 Neuroscience investors, A to Z
Grouped by first letter. Name and profile link only, the detailed rows are in the table above.ShowHide
A12
- Aaqil Anwar
- Adam Koppel
- Adam Lessler
- Adrien Cohen
- Alan O'Connell
- Alejandro Sanchez
- Alice Chen
- Ami Lebendiker
- Anatoly Tikhman
- Andrew Firlik
- Andrew Krowne
- Anne Grahl
B4
- Barbara T.
- Brandon Drew
- Brian Mulhall
- Brian Paegel
C1
- Cheryl Zimberlin
D10
- D.A. Wallach
- David Baszucki
- David Chappill
- David Fahrenkamp
- Debra Liebert
- Dirk Landgraf
- Dominik Escher
- Douglas Talbert
- Dragan Grabulovski
- Dusan Perovic
E1
- Emmanuel Lange
G2
- George Whitehead
- German Lemonnier
H1
- Hyunsun R.
I2
- Ian Garland
- Ian Howes
J14
- Jake Nunn
- Jasmina Marjanovic
- Jeanne Bolger
- Jim Lang
- Jim Wicks
- Jitendra Patel
- John F. Harris
- John Lee
- John Lee
- Jonathan Behr
- Joshua Cowgill
- Joshua Greene
- Joshua Rosamond
- Julie Gionfriddo
K7
- Karen Chan
- Karen Gill
- Katherine Terranova
- Ken Mariash
- Kiran Dallenbach
- Klaus Breiner
- Krishnan Akhileswaran
L9
- Larry Brownstein
- Lars Nieba
- Laurent Alexandre
- Lawrence Bloch
- Lekan Wang
- Liam Bradley
- Liam Ratcliffe
- Lin Ning
- Lowell Sears
M10
- Martin Münchbach
- Matt D.
- Maurice R Ferre
- Maurice Zauderer
- Merika Koday
- Michael Dearing
- Michal Tsur
- Milad Alucozai
- Miles Gerson
- Milton Boniuk
N1
- Ned Scheetz
P3
- Pamela Walker Geddes
- Pascal Levensohn
- Paul Fauset
R5
- R. Jordan Hall
- Rajat Malhotra
- Reetika B.
- Ricardo Dolmetsch
- Ron Rymon
S8
- Sam Fennell
- Scott Blumberg
- Scott Brun
- Scott Wharton
- Shailesh Maingi
- Simon Blakey
- Sina Ataherian
- Sina Habibi
T7
- Thomas Kodadek
- Thomas Putter
- Thong Le
- Tianqiao Chen
- Tim Barberich
- Tim Rosa
- Timothy Mills
V2
- Veronica Gambillara Fonck
- Vilas Dhar
W3
- Walter Carrion
- Walter Gilbert
- Will Vicars
X1
- Ximing Ding
Z1
- Zack Lynch
Frequently asked questions
How many Neuroscience investors are on RaiseHunt?
RaiseHunt currently lists 144 Neuroscience investors.
Are Neuroscience investors angels or funds?
Both. 85 are angel investors putting in their own money, and 59 are people making investment decisions at 23 firms.
Where are most Neuroscience investors based?
The largest concentrations are in Boston, San Francisco and London.
What stage do Neuroscience investors invest at?
Most list Seed and Series A among the rounds they take part in.
How do I contact Neuroscience investors?
Every profile shows whether an email address is on file. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.
Is the list of Neuroscience investors free to browse?
Yes. The directory and every profile page are free to read. Matching your own startup against them requires an account.
Do Neuroscience investors only back Neuroscience companies?
No. A focus area is a signal of interest, not a restriction. Investors usually list several, and the useful question is whether their existing portfolio looks like the kind of company you are building.
What is the difference between an angel investor and a VC fund?
An angel invests their own money and can decide alone, which usually makes the process shorter. A fund invests money it raised from other people, so it answers to those backers and normally runs a longer diligence process before it commits. Founders often raise from angels first and bring in a fund once there is more to show.
How many Neuroscience investors should I contact?
Far more than feels comfortable. Response rates on cold outreach are low even when the fit is good, so a list of a handful of perfect names tends to stall. Build a long list, sort it by how well each one matches what you are building, and work down it in batches rather than sending everything at once.
What should I have ready before reaching out?
A short deck, a one-paragraph description of what you do and who it is for, and a clear number for how much you are raising. Investors read the first two lines before they decide whether to open the deck, so those lines matter more than the rest of the document.
Does a warm introduction still matter?
It helps, mostly because it moves your email out of a crowded inbox. It is not a requirement. A cold message that shows you understand what someone has already backed, and why your company fits that pattern, gets read more often than a vague introduction from a distant contact.
How do I know which Neuroscience investors are a fit?
Look at what they have already funded rather than what their profile says they like. Stage matters most, then sector, then geography. An investor who has never funded anything at your stage is unlikely to start with you, however well the sector lines up.
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal
